Switching Language

Please note that your current login session is only valid on the English site (letpub.com). You will not be signed in on other language versions of the site. If you wish to place an order, please return to the English site.

    Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector


New Free Tool: Verity — Pre-Submission Manuscript Check
Automatically checks your manuscript across 34 criteria including structure, metadata, disclosures, and language issues before you submit to your target journal.
Try for Free →
  
  
-

INVESTIGATIONAL NEW DRUGS


👁  42507 Views

 45 Reviews  

 Open Access      SCIE      Official Website     Submission Website
 

*Average Peer Review
About 1.0 month(s)
*Competitiveness
Moderate
CiteScore
5.8
CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Pharmacology (medical)		 71 / 278
Category: Medicine
Subcategory: Oncology		 121 / 428
Category: Medicine
Subcategory: Pharmacology		 111 / 328
Link to PubMed Central (PMC)
https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-6997%5BISSN%5D

Indexing (SCI collection)
Science Citation Index Expanded (SCIE)
Scopus (CiteScore)

Country/Area of Publication
UNITED STATES
Publication Frequency
Quarterly
Publisher
Springer US

ISSN
0167-6997
E-ISSN
1573-0646
Year Publication Started
1983

Self-citation (2025-2026)
0.00%
Annual Article Volume
98
Gold OA Percentage
33.73%

Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A
Journal Aim & Scope
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.

Web of Science Quartiles
WOS Quartile: Q2

Quartiles By JIFCollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ2148/333
Category: PHARMACOLOGY & PHARMACYSCIEQ2143/356
Quartiles By JCICollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ2124/333
Category: PHARMACOLOGY & PHARMACYSCIEQ2120/356
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    TRENDS IN PHARMACOLOGICAL SCIENCES20132.40
    DRUG RESISTANCE UPDATES10029.10
    ADVANCED DRUG DELIVERY REVIEWS27839.00
    PHARMACOLOGICAL REVIEWS21025.90
    MEDICINAL RESEARCH REVIEWS11929.10
    PHARMACOLOGY & THERAPEUTICS18028.30
    PHARMACOLOGICAL RESEARCH11819.10
    PHYTOMEDICINE10513.20
    DRUG DISCOVERY TODAY15716.80
    ARCHIVES OF PHARMACAL RESEARCH7513.60
  • INVESTIGATIONAL NEW DRUGS INVESTIGATIONAL NEW DRUGS
    Predict CiteScore Trend：
    Steady Increase No Change Gradual Decline　 Refresh
 
    👁  42507 Views
    ☰  Reviews        
 
 
 

Select your rating and start your review of INVESTIGATIONAL NEW DRUGS

 

    Journals In The Same Field
    CA-A CANCER JOURNAL FOR CLINICIANS
    CiteScore: 649.80
    NATURE REVIEWS DRUG DISCOVERY
    CiteScore: 159.20
    MMWR Recommendations and Reports
    CiteScore: 131.20
    Nature Reviews Clinical Oncology
    CiteScore: 126.60
    Kidney International Supplements
    CiteScore: 117.70
    NATURE REVIEWS CANCER
    CiteScore: 96.20
    MMWR Surveillance Summaries
    CiteScore: 93.20
    LANCET
    CiteScore: 92.40
    World Psychiatry
    CiteScore: 84.80
    World Psychiatry
    CiteScore: 84.80



    © 2010-2026  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
    Privacy • Terms of Servic